Perrigo’s ProAir Rival ‘Unlikely To Be Back In 2021’ Following Recall
Q3 2020 Recall Led To $200m Impairment Charge
Perrigo has moved to allay more serious concerns around its generic ProAir inhaler device, but concedes that it is highly unlikely the lucrative respiratory product will return to the market this year.
